Piyush Gondaliya

Opposite Air Force Station
Ghandinagar, GJ 382355, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Engineered Natural Killer Cell Derived-Extracellular Vesicles: An Acellular Immunotherapy with Cytotoxic Effects in SNU-1079 Human Cholangiocarcinoma Cells.

Engineered Natural Killer Cell Derived-Extracellular Vesicles: An Acellular Immunotherapy with Cytotoxic Effects in SNU-1079 Human Cholangiocarcinoma Cells.

Journal: Molecular pharmaceutics

Published: February 16, 2026

CAR-T cells directed toward PD-L1 demonstrate potent, antigen-specific activity against cholangiocarcinoma: A proof of concept study.

CAR-T cells directed toward PD-L1 demonstrate potent, antigen-specific activity against cholangiocarcinoma: A proof of concept study.

Journal: Molecular therapy. Oncology

Published: November 21, 2025

Correction: Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition.

Correction: Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition.

Journal: Oncotarget

Published: November 14, 2025

Cell-SELEX identifies a DNA aptamer for highly selective in vivo siRNA delivery in cholangiocarcinoma.

Cell-SELEX identifies a DNA aptamer for highly selective in vivo siRNA delivery in cholangiocarcinoma.

Journal: JHEP reports : innovation in hepatology

Published: September 02, 2025

Global and regional mortality rate statistics of mpox (formerly monkeypox): a comprehensive systematic review and meta-analysis.

Global and regional mortality rate statistics of mpox (formerly monkeypox): a comprehensive systematic review and meta-analysis.

Journal: Pathogens and global health

Published: August 30, 2025

Imidazopyrimidine-based pyruvate kinase M2 activator halts diabetic nephropathy progression via modulating epithelial-to-mesenchymal transition and fibrosis.

Imidazopyrimidine-based pyruvate kinase M2 activator halts diabetic nephropathy progression via modulating epithelial-to-mesenchymal transition and fibrosis.

Journal: Chemico-biological interactions

Published: March 10, 2025

Using aptamers for targeted delivery of RNA therapies.

Using aptamers for targeted delivery of RNA therapies.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 05, 2024

In Silico Design of Novel EpCAM-Binding Aptamers for Targeted Delivery of RNA Therapeutics.

In Silico Design of Novel EpCAM-Binding Aptamers for Targeted Delivery of RNA Therapeutics.

Journal: Nanomaterials (Basel, Switzerland)

Published: October 09, 2024

Global and regional mortality statistics of nipah virus from 1994 to 2023: a comprehensive systematic review and meta-analysis.

Global and regional mortality statistics of nipah virus from 1994 to 2023: a comprehensive systematic review and meta-analysis.

Journal: Pathogens and global health

Published: July 20, 2024

Targeting PD-L1 in cholangiocarcinoma using nanovesicle-based immunotherapy.

Targeting PD-L1 in cholangiocarcinoma using nanovesicle-based immunotherapy.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 04, 2023

Engineering Cell-Derived Nanovesicles for Targeted Immunomodulation.

Engineering Cell-Derived Nanovesicles for Targeted Immunomodulation.

Journal: Nanomaterials (Basel, Switzerland)

Published: September 12, 2023

Therapeutic restoration of miR-126-3p as a multi-targeted strategy to modulate the liver tumor microenvironment.

Therapeutic restoration of miR-126-3p as a multi-targeted strategy to modulate the liver tumor microenvironment.

Journal: Hepatology communications

Published: May 24, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026